giles AI announced the commercial launch of its specialised AI research agent, designed to help healthcare, clinical and medical researchers work with scientific evidence.
By extracting, analysing, summarising and referencing information from medical databases and private files, giles® connects the steps of literature review in a single research workflow.
- Connected access to medical and life sciences research, alongside researchers’ own documents.
- Scientific text comprehension, data extraction and citation tracking in one workflow.
- Support for research conversations and outputs in more than 40 languages.
A research partner that understands the context
Scientific research involves more than finding a paper. Researchers need to understand the methods, compare results and follow the evidence behind each conclusion.
giles® brings those activities together. Users can search trusted sources, explore private documents, create summaries and compare findings, with references that help them return to the original material.
Developed around real research
Following its initial development, refinement and commercialisation of the agent were supported by a strategic partnership with Regulatory Scientific and Health Solutions (R-S-S), bringing expertise in health economics, drug development and evidence synthesis.
The launch announcement also described ongoing support from Google UK and collaborations connecting researchers with medical databases.
“We are excited to share giles with both academics and researchers from across sector as we advance in our mission to make advanced AI research tools available to all.”
Rishi Wadhera
Chief Executive Officer, giles AI
From information to understanding
The commercial launch marks a step towards the company’s ambition to make advanced research tools accessible, helping teams spend more time interpreting the evidence and less time assembling it.
Explore the platform, read the published extraction evaluations or speak to the team about your research workflow.